CN103690811A - Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof - Google Patents
Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof Download PDFInfo
- Publication number
- CN103690811A CN103690811A CN201310715407.8A CN201310715407A CN103690811A CN 103690811 A CN103690811 A CN 103690811A CN 201310715407 A CN201310715407 A CN 201310715407A CN 103690811 A CN103690811 A CN 103690811A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- fructus
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 48
- 239000007788 liquid Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 208000002173 dizziness Diseases 0.000 title abstract description 28
- 230000036772 blood pressure Effects 0.000 title abstract description 17
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 241000628997 Flos Species 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 229940013618 stevioside Drugs 0.000 claims description 6
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 6
- 235000019202 steviosides Nutrition 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 241000219295 Portulaca Species 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 241000245240 Lonicera Species 0.000 claims description 2
- 235000009815 Momordica Nutrition 0.000 claims description 2
- 241000218984 Momordica Species 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 14
- 206010020772 Hypertension Diseases 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 8
- 230000004438 eyesight Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 206010033557 Palpitations Diseases 0.000 abstract description 4
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract description 3
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 2
- 240000003915 Lophatherum gracile Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 206010003549 asthenia Diseases 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 206010047513 Vision blurred Diseases 0.000 description 20
- 208000031226 Hyperlipidaemia Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 10
- -1 flavone compound Chemical class 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 230000035487 diastolic blood pressure Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 230000009978 visual deterioration Effects 0.000 description 5
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000012886 Vertigo Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000889 vertigo Toxicity 0.000 description 4
- 208000000044 Amnesia Diseases 0.000 description 3
- 208000031091 Amnestic disease Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 230000006986 amnesia Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- NWUMSRKLBRWRAS-UHFFFAOYSA-N Arundoin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CC(C)(C)CCC5(C)CCC34C)C1(C)C NWUMSRKLBRWRAS-UHFFFAOYSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000032139 Halitosis Diseases 0.000 description 2
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241001044169 Parum Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000015263 low fat diet Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-FXUDXRNXSA-N (S)-atropine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@H]3CC[C@@H](C2)N3C)=CC=CC=C1 RKUNBYITZUJHSG-FXUDXRNXSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 241000722818 Aralia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- MRNPHCMRIQYRFU-KXUMSINMSA-N Arundoin Chemical compound C([C@]1(C)[C@@H](C(C)C)CC[C@H]1[C@]1(C)CC=C23)C[C@]1(C)[C@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-KXUMSINMSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- MRNPHCMRIQYRFU-UWAWSDATSA-N Cylindrin Chemical compound C([C@@]1(C)[C@H](C(C)C)CC[C@@H]1[C@@]1(C)CC=C23)C[C@@]1(C)[C@@H]3CC[C@@H]1[C@]2(C)CC[C@H](OC)C1(C)C MRNPHCMRIQYRFU-UWAWSDATSA-N 0.000 description 1
- BRQBMPGDACUHNR-UHFFFAOYSA-N Cylindrin Natural products COC1CCC2(C)C(CCC3C2=CCC4(C)C5CCC(C(C)C)C5CCC34C)C1(C)C BRQBMPGDACUHNR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- XACHQDDXHDTRLX-GMPBGBGESA-N Physalien Natural products O=C(O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=2C(C)(C)C[C@H](OC(=O)CCCCCCCCCCCCCCC)CC=2C)\C)/C)\C)/C)=C(C)C1)CCCCCCCCCCCCCCC XACHQDDXHDTRLX-GMPBGBGESA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- VQKFNUFAXTZWDK-UHFFFAOYSA-N alpha-methylfuran Natural products CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 108010089310 cylindrin Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960003210 hyoscyamine Drugs 0.000 description 1
- 229930005342 hyoscyamine Natural products 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229930184989 physalin Natural products 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- XACHQDDXHDTRLX-HZXCUAKRSA-N zeaxanthin dipalmitate Chemical compound CC1(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CC(OC(=O)CCCCCCCCCCCCCCC)CC1(C)C XACHQDDXHDTRLX-HZXCUAKRSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine oral liquid for lowering blood pressure, preventing dizziness and regulating blood fat and a preparation method thereof. The oral liquid is prepared from the following active pharmaceutical ingredients in parts by weight: 20-50 parts of gynostemma pentaphyllum, 10-30 parts of honeysuckle flower, 10-30 parts of chrysanthemum flower, 10-30 parts of hawthorn, 10-30 parts of fructus momordicae, 10-20 parts of wolfberry fruit, 5-20 parts of radix salviae miltiorrhizae, 2-10 parts of lophatherum gracile and 2-10 parts of purslane. The oral liquid is strict in prescription, has the effects of lowering blood pressure and blood fat, clearing heat, improving eyesight and the like, and has favorable curative effects on hypertension caused by hyperlipemia, dizziness, palpitation, asthenia, hyperlipemia, obesity and the like. All the active pharmaceutical ingredients except the gynostemma pentaphyllum are medicinal and edible drugs, so the oral liquid is safe to use; and the oral liquid contains abundant nutrient substances and effective components capable of improving human health and treating diseases, and thus, can supplement nutrients required by the human body and enhance the immunity.
Description
?
Technical field
The invention belongs to medicine field, relate to a kind of Chinese medicine oral liquid and preparation method thereof.
Background technology
Hypertension is a pair of " twin brothers " of modern chronic disease with feeling dizzy, it is as chronic disease, interactional, therefore, blood pressure is higher throughout the year, often cause the not clear symptoms such as patient's headache, dim eyesight, tinnitus, and patient is because feeling dizzy, usually cause cardiopalmus, the long-time anxiety of spirit etc., likely cause hypertension.
Chinese medicine is the product of the distinctive Chinese medical theory of China and practice, aboundresources, with a long history, it is the pure natural organic material that the mankind apply the earliest, wherein part Chinese medicine often by people as food consumption, the very high medical value of tool again, " integration of edible and medicinal herbs " kind, has the two-way function of nutrition and treatment concurrently.Along with growth in the living standard, people are to health also pay attention to day by day, therefore the product that hope is used is also safely and effectively, and " integration of edible and medicinal herbs " class Chinese medicine meets people's treatment disease, health care demand.The present invention especially for hypertension complicated with dizziness and blurred vision, patient, work out a kind of Chinese medicine oral liquid safely and effectively, at present, there is not yet relevant report.
Summary of the invention
The object of the invention is to follow dizziness and blurred vision, the weak patient of cardiopalmus for hypertension, hyperlipidemia, a kind of Chinese medicine oral liquid and preparation method thereof is provided.
Inventor is by this distinctive medical material of Herb Gynostemmae Pentaphylli, in conjunction with selecting suitable raw material in " integration of edible and medicinal herbs " class Chinese medicine, by long-term practice reasonable preparation, make a kind of Chinese medicine oral liquid, this Chinese medicine oral liquid contains abundant nutrient substance and treatment disease and improves the effective ingredient of health, and there is pleasant aromatic odor, mouthfeel is good, there is blood pressure lowering, adjust blood fat, heat clearing away, the effects such as improving eyesight, can obviously improve because of hypertension, the dizziness and blurred vision causing that hyperlipidemia joint effect causes, visual deterioration patient's symptom, the nutrition that can also supplement needed by human body simultaneously, reach treatment hyperlipidemia with dizziness and blurred vision, cardiopalmus is weak, visual deterioration disease, improve immunity, lowering blood-fat and reducing weight, the object of improving the quality of living.
The technical solution adopted in the present invention is as follows:
A Chinese medicine oral liquid, is made by the crude drug of following weight part ratio: Herb Gynostemmae Pentaphylli 20-50 part, Flos Lonicerae 10-30 part, Flos Chrysanthemi 10-30 part, Fructus Crataegi 10-30 part, Fructus Momordicae 10-30 part, Fructus Lycii 10-20 part, Radix Salviae Miltiorrhizae 5-20 part, Herba Lophatheri 2-10 part, Herba Portulacae 2-10 part.
The above Chinese medicine oral liquid, is preferably made by the crude drug of following weight part ratio: 30 parts of Herb Gynostemmae Pentaphylli, 30 parts of Flos Loniceraes, 20 parts of Flos Chrysanthemis, 20 parts of Fructus Crataegis, 20 parts of Fructus Momordicaes, 15 parts of Fructus Lycii, 15 parts of Radix Salviae Miltiorrhizaes, 5 parts of Herba Lophatheris, 5 parts of Herba Portulacaes.
The preparation method of the above Chinese medicine oral liquid, comprises the following steps:
A. get respectively Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae, clean, dry;
B. take by weight: Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae;
C. load weighted Chinese medicine is added to 5-10 times of water gaging heating and refluxing extraction 2-3 time, each 1-3 hour, filters merging filtrate;
D. gained filtrate is concentrated into relative density 1.20～1.25(60 ℃) clear paste, add 6-10 times of water gaging, stir evenly, standing 24～48 hours, leaching supernatant;
E. supernatant concentration is extremely appropriate, add antiseptic, correctives, boil and make to dissolve, add water to 100 parts, stir evenly, filter, sterilizing, obtains.
Described antiseptic can be one or more the combination in benzoic acid, sodium benzoate, methyl parahydroxybenzoate, ethylparaben, sorbic acid, potassium sorbate etc., is preferably sodium benzoate.Described correctives is that one or more the combinatorial optimization in sucrose, simple syrup, sorbitol, mannitol, stevioside, radix asparagi sweet extract etc. is stevioside.
The present invention is on the basis of Chinese medicine traditional theory, in conjunction with medication experience among the people, uses modern scientific theory formulated.Prescription of the present invention is rigorous, parum drug and centralize the power, there is blood pressure lowering, adjust the effects such as blood fat, heat clearing away, improving eyesight, thereby mainly by adjusting hyperlipidemia to hypertension symptom is improved, and improve the symptoms such as dizziness and blurred vision, cardiopalmus that hypertension, hyperlipidemia causes is weak, and improve immunity, cosmetic slimming, have good curative effect.
(1) Herb Gynostemmae Pentaphylli, Herb Gynostemmae Pentaphylli, is perennial herbaceous stem rattan wood, claims again that paradise grass, Gospel are careless, superman's ginseng, Herb Gynostemmae Pentaphylli, Herba Gynostemmatis, Herba Gynostemmatis, Pentapanax and gynostemma pentaphyllum makino etc., Japan is referred to as sweet climing tea.Herb Gynostemmae Pentaphylli is liked the weather of dark and damp gentleness, how wild in concealments place such as sylvan life, brook banks, the perennial draft of climbing up by holding on to.
[nature and flavor with return through] bitter in the mouth; Micro-sweet; Cool in nature.Return lung; Spleen; Kidney channel.
[function with cure mainly] replenishing QI to invigorate the spleen, preventing phlegm from forming and stopping coughing, heat-clearing and toxic substances removing.Body void is weak; Nephrasthenia emission; Leukopenia; Hyperlipemia; Viral hepatitis; Chronic gastroenteritis; Chronic tracheitis.
(1) Herb Gynostemmae Pentaphylli is mainly distributed in Shaanxi flat interest, Hunan, Hubei in China, the province such as Yunnan, Guangxi, be known as " southern Radix Ginseng ", be grown in the medicinal content of southern Herb Gynostemmae Pentaphylli higher, " the elixir grass " of being called mystery among the people, 1986, State Scientific and Technological Commission was in Spark Program, Herb Gynostemmae Pentaphylli is classified as to position first of " rare Chinese medicine " leaved for development, and on March 5th, 2002, health ministry was listed in health product list.
(2) Fructus Crataegi is the dried leaves of rosaceous plant Fructus Pyri Pashiae Crataegus pinnatifida Bge.var.major N.E.Br. or Fructus Crataegi Grataegus pinnati fida Bge..< < Chinese Pharmacopoeia > > version in 2010 is recorded: [nature and flavor with return through] acid, and flat.Return Liver Channel.[function with cure mainly] blood circulation promoting and blood stasis dispelling, regulates the flow of vital energy and promotes blood circulation, and changes turbid blood fat reducing.For qi depression to blood stasis, obstruction of qi in the chest and cardialgia, chest distress. palpitation and amnesia, vertigo and tinnitus, hyperlipemia.
Fructus Crataegi energy prevention and cure of cardiovascular disease, has blood vessel dilating, heart tonifying, increase coronary flow, improves heart vigor, stimulating central nervous system system, reduces blood pressure and cholesterol, vessel softening and diuresis and sedation; Prevent and treat arteriosclerosis, anti-aging, anticancer effect.
(3) Flos Chrysanthemi is the dry capitulum of feverfew chrysanthemum Chrysanthemum morifolium Ramat..< < Chinese Pharmacopoeia > > version in 2010 is recorded: [nature and flavor with return through] are sweet, bitter, are slightly cold.Return lung, Liver Channel; [function with cure mainly] loose wind heat clearing away, suppressing the hyperactive liver improving eyesight, heat-clearing and toxic substances removing.For anemopyretic cold, have a headache dizzy, conjunctival congestion and swelling pain, eyes is dim-sighted, sore and toxic.
Flos Chrysanthemi is different with kind because of the place of production, and its chemical composition has certain difference.The chemical constitution study of the Flos Chrysanthemi in four kinds of sources that pharmacopeia is recorded all has report research to find, the chemical composition more complicated of Flos Chrysanthemi, and wherein flavone compound, triterpenoid compound and volatile oil are its main effective ingredient.
(4) Flos Lonicerae is dry flower or the first flower of opening of band of caprifoliaceae plant Radix Ophiopogonis Lonicera japonica Thunb..The flowers are in blossom gathers before putting for early summer, dry.Within 1984, State Administration of Traditional Chinese Medicine is defined as one of 35 kinds of rare Chinese medicines, is confirmed as again afterwards dietotherapeutic kind.< < Chinese Pharmacopoeia > > version in 2010 is recorded:
[nature and flavor with return through]sweet, cold.Return lung, the heart, stomach warp.
[function with cure mainly]heat-clearing and toxic substances removing, dispelling wind and heat pathogens.For carbuncle, treat skin ulcer, sore throat, erysipelas, toxic-heat and blood stasis, anemopyretic cold, epidemic febrile disease heating.
(5) Fructus Momordicae is the dry fruit of cucurbitaceous plant Fructus Momordicae Siraiti grosvenorii (Swin gle) C.Jeffrey ex A. M. Lu et Z.Y.Zhang.< < Chinese Pharmacopoeia > > version in 2010 is recorded:
[nature and flavor with return through]sweet, cool.Return lung, large intestine channel.
[function with cure mainly]clearing heat and moistening lung, relieving sore throat to recover voice, laxation relieving constipation.For lung-heat type cough, pharyngalgia aphonia, dryness of the intestine constipation.
(6) Fructus Lycii is the dry mature fruit of plant of Solanaceae lycium barbarum Lycium barbarum L..< < Chinese Pharmacopoeia > > version in 2010 is recorded: [nature and flavor with return through] are sweet, flat, return liver, kidney channel; [function with cure mainly] nourishing the liver and kidney, replenishing vital essence to improve eyesight.For asthenia damage of essence, soreness of waist and knee joint, vertigo and tinnitus, interior-heat is quenched one's thirst, blood deficiency and yellow complexion, blurred vision is not clear.Fructus Lycii is in the notice > > of the < < that announces of Ministry of Public Health 2002 about further standard healthy food material management to be one of food and drug list.
Fructus Lycii is containing betanin, physalin, atropine 0.95%, hyoscyamine, scopoletin 0.29%, polysaccharide 5.42%～8.23%, cryptoxanthine, several amino acids, vitamin B1, B2, C, nicotinic acid, taurine, reducing sugar 34.83%, total sugar 37.85%.Seed contains volatile oil and multiple sterol.
(7) Radix Salviae Miltiorrhizae is dry root and the rhizome of labiate Radix Salviae Miltiorrhizae Salvia miltiorrhiza Bge..< < Chinese Pharmacopoeia > > version in 2010 is recorded: [nature and flavor with return through] hardship, is slightly cold.GUIXIN, Liver Channel.[function with cure mainly] blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia, the relieving restlessness that clears away heart-fire, removing heat from blood eliminating carbuncle.For obstruction of qi in the chest and cardialgia, gastral cavity abdomen hypochondriac pain, abdominal mass abdominal mass is gathered, pyretic arthralgia pain, and dysphoria and insomnia, menoxenia, dysmenorrhea amenorrhea, skin infection swells and ache.
(8) Herba Lophatheri is the dry stem and leaf of grass Herba Lophatheri Lophatherum gracile Brongn..< < Chinese Pharmacopoeia > > version in 2010 is recorded: [nature and flavor with return through] are sweet, light, cold, GUIXIN, stomach, small intestine meridian; [function with cure mainly] clearing heat and relieving fidgetness, diuresis, drench pain, aphtha of the mouth and tongue for calentura excessive thirst, hot urination.In the notice > > that the < < announcing for 2002 for Ministry of Public Health manages about further standard healthy food material, be one of food and drug list.
Herba Lophatheri contains a large amount of flavone compounds and bioactive polysaccharide and other effective ingredient, as phenolic acid compound, anthraquinone analog compound, terpene lactone, extraordinary aminoacid and active skin, manganese, zinc, selenium and other trace elements.Separately there are report Arundoin, Cylindrin, taraxasterol, freidelin, stigmasterol, cupreol, campesterol etc.Wherein contained functional factor is mainly flavone glycoside and Coumarins lactone, and its content and biological activity effectively becoming all has comparability with Folium Ginkgo.Modern pharmacological research shows, Herba Lophatheri has refrigeration function, separately has the effect of good free radical resisting, antioxidation, defying age, blood fat reducing and cholesterolemia.
(9) Herba Portulacae is the dry aerial parts of portulacaceous plant Herba Portulacae Portulaca oleraceaL..[
nature and flavor with return through] acid, cold.Return liver, large intestine channel.< < Chinese Pharmacopoeia > > version in 2010 is recorded: [
function with cure mainly] heat-clearing and toxic substances removing, cooling blood for hemostasis, dysentery relieving.For toxic-heat and blood stasis, carbuncle is treated skin ulcer, eczema, and erysipelas, snake bite and insect sting, has blood in stool, hemorrhoidal bleeding, metrostaxis.
Herba Portulacae is felt dizzy and records to some extent in some ethnic groups medicine will for treatment:
[Blang's medicine] Zong Xinduo: herb is controlled dizziness and blurred vision < < Yunnan medicine record > >.Zong Xinduo: Herb is outer for dizziness and blurred vision < < Yunnan province will > >.Zong Xinduo: herb cures mainly dizziness and blurred vision < < ethnic drug will two > >.
[Dai Nationality's medicine] handkerchief eight good (the western Dai Nationality), tooth west code, bud seat horse (the moral Dai Nationality): herb is controlled cough due to lung-heat, dysentery < < Yunnan medicine record > >.Handkerchief is mixed cool: Herb is for cough due to lung-heat, dysentery < < Yunnan province will > >.Handkerchief plate is good: the nervous heart beating for the treatment of, headache, pneumonopathy, the medicine > > of the knife injury < < Dai Nationality.Handkerchief is mixed cool: herb is controlled nervous heart beating, headache, and pulmonary tuberculosis, knife injury, sprains, and synthetism muscle continues the < < medicine will > > of the Dai Nationality.Bud seat horse: herb cures mainly cough due to lung-heat < < ethnic drug will two > >.
The invention has the beneficial effects as follows:
(1) crude drug be take " integration of edible and medicinal herbs " kind as main, use safety, toxic and side effects less, in conjunction with the Herb Gynostemmae Pentaphylli that originates in Jinxiu Yao ethnic group in Guangxi province autonomous county, this saponin active constituent content exceeds the Herb Gynostemmae Pentaphylli kind of average national level nearly 30%, can reach good effect.Herb Gynostemmae Pentaphylli, through Chinese scholars long-term research, is not found Herb Gynostemmae Pentaphylli toxic side effect, therefore, can combine preferably with the medical material of other components in the present invention's " integration of edible and medicinal herbs ", reaches the effect of good Synergistic.
(2) prescription is rigorous, parum drug and centralize the power, has the effects such as blood fat reducing, heat clearing away, improving eyesight, to symptoms such as the dizziness and blurred vision, the cardiopalmus that regulate hyperlipidemia to cause hypertension to cause are weak, and improve immunity, cosmetic slimming, have good curative effect, cure rate is more than 81%.
(3) contain abundant nutrient substance and improve health and treatment disease effective ingredient, and there are pleasant aromatic odor, mouthfeel good, not containing sucrose, applicable diabetics is taken, can also supplement nutrition, the raising immunity of needed by human body, the object of reach health care, improve looks, improving the quality of living.
(4) prescription is selected Chinese Minority Nationalities medicine, overcomes the formula of prior art employing without the defect of ethnic groups formula;
(5) the present invention adopts modern advanced technologies preparation, and the transparent clarification of gained oral liquid, does not have deposited phenomenon.
The specific embodiment
Below in conjunction with specific embodiment, the invention will be further described, but do not limit the scope of the invention and range of application:
one, the preparation of oral liquid
1. EXPERIMENTAL DESIGN:
This test is prepared into respectively oral liquid with 5 embodiment, and design parameter refers to table 1.
Table 1 embodiment preparation parameter table
| Embodiment | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 |
| Herb Gynostemmae Pentaphylli (kg) | 20 | 45 | 30 | 50 | 35 |
| Flos Lonicerae (kg) | 30 | 10 | 15 | 20 | 25 |
| Flos Chrysanthemi (kg) | 20 | 30 | 25 | 15 | 10 |
| Fructus Crataegi (kg) | 30 | 20 | 15 | 10 | 25 |
| Fructus Momordicae (kg) | 10 | 25 | 20 | 30 | 20 |
| Fructus Lycii (kg) | 10 | 12 | 15 | 20 | 10 |
| Radix Salviae Miltiorrhizae (kg) | 2 | 8 | 12 | 15 | 18 |
| Herba Lophatheri (kg) | 2 | 8 | 5 | 10 | 3 |
| Herba Portulacae (kg) | 2 | 8 | 5 | 10 | 3 |
| Extract amount of water (doubly) | 5 | 8 | 8 | 10 | 6 |
| Extraction time (inferior) | 3 | 2 | 3 | 2 | 2 |
| Time (h/ time) | 1 | 2 | 1 | 1 | 3 |
| Relative density (60 ℃) | 1.20 | 1.25 | 1.22 | 1.23 | 1.23 |
| Water precipitating amount of water (doubly) | 6 | 10 | 8 | 8 | 7 |
| Antiseptic | Sodium benzoate | Methyl parahydroxybenzoate | Sodium benzoate | Potassium sorbate | Ethylparaben |
| Correctives | Sucrose | Stevioside | Stevioside | Stevioside | Radix asparagi sweet extract |
2. operating procedure:
(1) get respectively Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae, clean, dry;
(2) by above weight part ratio, take respectively: Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae;
(3) load weighted Chinese medicine is added to 5-10 times of water gaging heating and refluxing extraction 2-3 time, each 1-3 hour, filters merging filtrate;
(4) gained filtrate is concentrated into relative density 1.20～1.25(60 ℃) clear paste, add 6-10 times of water gaging, stir evenly, standing 24～48 hours, leaching supernatant;
(5) supernatant concentration is extremely appropriate, add antiseptic, correctives, boil and make to dissolve, add water to 100kg, stir evenly, filter, sterilizing, obtains.
two, clinical practice
The present invention was once used for the treatment of and observed 50 routine patients.By above-mentioned 5 kinds of embodiment samples that prepare, be respectively used to hyperlipidemia and be attended by hypertension symptom, frequently easily feel dizziness and blurred vision, the weak patient of cardiopalmus (male 30 examples, female's 20 examples, 49.6 years old mean age) throughout the year.The results detailed in Table 2.
Table 2 clinical application effect table
| Embodiment | Recovery from illness (%) | Improve (%) | Invalid (%) |
| Embodiment 1 | 70 | 20 | 10 |
| Embodiment 2 | 60 | 20 | 20 |
| Embodiment 3 | 80 | 10 | 10 |
| Embodiment 4 | 90 | 10 | 0 |
| Embodiment 5 | 80 | 10 | 10 |
Result shows: adopt Chinese medicine oral liquid of the present invention, use safety, effective, the dizziness and blurred vision that hyperlipidemia, hypertension are caused, the weak patient of cardiopalmus have good curative effect, can supplement simultaneously needed by human body nutrition, improve immunity, the object of improve immunity, cosmetic slimming, improving the quality of living.Be below several model cases:
Case 1: thank * *, female, 26 years old, because hyperlipidemia, blood pressure are higher, systolic pressure was at 140～160mmHg throughout the year, and diastolic pressure is in 90～95mmHg scope.Be accompanied by dizziness and blurred vision, visual deterioration, cardiopalmus, the symptom such as weak.Take the embodiment of the present invention 1, each 2 (10ml/ props up), every day 4 times, serve on 90, coordinate low fat diet, blood pressure and rate and blood-lipid decreased are to normal level simultaneously, and dizziness and blurred vision symptom is eliminated, visual deterioration, cardiopalmus, the remission such as weak, appetite increases, energetic.
Case 2: Lee * *, man, 65 years old, hyperlipidemia accompanied dizziness, visual deterioration, build obesity, strenuous exercise can cause obstruction of qi in the chest and cardialgia symptom to be therefore slow in action.Take the embodiment of the present invention 2, each 3 (10ml/ props up), every day 3 times, serve on 90, coordinate low fat diet simultaneously, and rate and blood-lipid decreased is alleviated to some extent to normal level,, obstruction of qi in the chest and cardialgia symptom clear depending on thing; Blood pressure is by original, and systolic pressure is at 145～160mmHg throughout the year, and diastolic pressure, in 90～95mmHg scope, is reduced to 135～150mmHg, and diastolic pressure is in 85～92mmHg scope, and the 2kg that loses weight is energetic.
Case 3: king * *, female, 39 years old, hyperlipidemia accompanied dizziness and blurred vision, oliguria, constipation, blood pressure is higher, and systolic pressure is at 130～165mmHg throughout the year, and diastolic pressure is in 85～95mmHg scope.Take the embodiment of the present invention 3, each 1 (10ml/ props up), every day 3 times, serve on 45, and blood fat, blood pressure drops are to normal level, the remissions such as dizziness and blurred vision, oliguria, constipation.
Case 4: yellow * *, man, 45 years old, hyperlipidemia accompanied dizziness and blurred vision, halitosis, xerostomia excessive thirst, blood pressure were higher.Take the embodiment of the present invention 4, each 1 (10ml/ props up), every day 3 times, serve on 60, and blood fat, blood pressure drops are to normal level, the remissions such as dizziness and blurred vision, halitosis, xerostomia excessive thirst, oliguria constipation.
Case 5: blue * *, female, 58 years old, hyperlipidemia accompanied dizziness and blurred vision, palpitation and amnesia, vertigo and tinnitus, blood pressure is higher, and systolic pressure is at 140～165mmHg throughout the year, and diastolic pressure is in 85～95mmHg scope.Take the embodiment of the present invention 5, each 1 (10ml/ props up), every day 3 times, serve on 90, and blood fat, blood pressure drops are to normal level, dizziness and blurred vision, palpitation and amnesia, the remissions such as vertigo and tinnitus.
Claims (4)
1. a Chinese medicine oral liquid, it is characterized in that, by the crude drug of following weight part ratio, made: Herb Gynostemmae Pentaphylli 20-50 part, Flos Lonicerae 10-30 part, Flos Chrysanthemi 10-30 part, Fructus Crataegi 10-30 part, Fructus Momordicae 10-30 part, Fructus Lycii 10-20 part, Radix Salviae Miltiorrhizae 5-20 part, Herba Lophatheri 2-10 part, Herba Portulacae 2-10 part.
2. Chinese medicine oral liquid according to claim 1, it is characterized in that, by the crude drug of following weight part ratio, made: 30 parts of Herb Gynostemmae Pentaphylli, 30 parts of Flos Loniceraes, 20 parts of Flos Chrysanthemis, 20 parts of Fructus Crataegis, 20 parts of Fructus Momordicaes, 15 parts of Fructus Lycii, 15 parts of Radix Salviae Miltiorrhizaes, 5 parts of Herba Lophatheris, 5 parts of Herba Portulacaes.
3. a preparation method for Chinese medicine oral liquid as claimed in claim 1 or 2, is characterized in that comprising the following steps:
(1) get respectively Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae, clean, dry;
(2) take by weight: Herb Gynostemmae Pentaphylli, Flos Chrysanthemi, Fructus Crataegi, Flos Lonicerae, Fructus Momordicae, Fructus Lycii, Radix Salviae Miltiorrhizae, Herba Lophatheri, Herba Portulacae;
(3) load weighted Chinese medicine is added to 5-10 times of water gaging heating and refluxing extraction 2-3 time, each 1-3 hour, filters merging filtrate;
(4) gained filtrate is concentrated into relative density 1.20～1.25(60 ℃) clear paste, add 6-10 times of water gaging, stir evenly, standing 24～48 hours, leaching supernatant;
(5) supernatant concentration is extremely appropriate, add antiseptic, correctives, boil and make to dissolve, add water to 100 parts, stir evenly, filter, sterilizing, obtains.
4. the preparation method of Chinese medicine oral liquid according to claim 3, is characterized in that, described antiseptic is sodium benzoate, and described correctives is stevioside.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310715407.8A CN103690811A (en) | 2013-12-23 | 2013-12-23 | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310715407.8A CN103690811A (en) | 2013-12-23 | 2013-12-23 | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103690811A true CN103690811A (en) | 2014-04-02 |
Family
ID=50352581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310715407.8A Pending CN103690811A (en) | 2013-12-23 | 2013-12-23 | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103690811A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893389A (en) * | 2014-04-15 | 2014-07-02 | 蚌埠火鹤制药有限公司 | Traditional Chinese medicinal tea drink for reducing blood pressure |
| CN104840536A (en) * | 2015-05-28 | 2015-08-19 | 徐艳 | Traditional Chinese medicine composition used for treating palpitation |
| CN106074854A (en) * | 2016-06-25 | 2016-11-09 | 罗健 | A kind of Chinese medicine health-care oral liquid and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102423381A (en) * | 2011-12-30 | 2012-04-25 | 苏州爱斯欧蒂生物科技有限公司 | Health tea with lipid-lowering effect |
| CN102657791A (en) * | 2012-06-04 | 2012-09-12 | 韦东波 | Chinese medicinal composition containing pale butterflybush flower and preparation method thereof |
-
2013
- 2013-12-23 CN CN201310715407.8A patent/CN103690811A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102423381A (en) * | 2011-12-30 | 2012-04-25 | 苏州爱斯欧蒂生物科技有限公司 | Health tea with lipid-lowering effect |
| CN102657791A (en) * | 2012-06-04 | 2012-09-12 | 韦东波 | Chinese medicinal composition containing pale butterflybush flower and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 朱德礼等: "清眩宁治疗高血压病并高血脂症225例疗效分析", 《中国医药导报》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893389A (en) * | 2014-04-15 | 2014-07-02 | 蚌埠火鹤制药有限公司 | Traditional Chinese medicinal tea drink for reducing blood pressure |
| CN104840536A (en) * | 2015-05-28 | 2015-08-19 | 徐艳 | Traditional Chinese medicine composition used for treating palpitation |
| CN106074854A (en) * | 2016-06-25 | 2016-11-09 | 罗健 | A kind of Chinese medicine health-care oral liquid and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101564122B (en) | Summer-heat clearing-away fruit jelly and preparation method thereof | |
| CN112121144B (en) | Roxburgh rose composition and preparation method and application thereof | |
| CN103740558A (en) | Dendrobium nobile wine and preparation method thereof | |
| CN103735897A (en) | Traditional Chinese medicine oral liquid for lowering blood pressure and regulating blood fat and preparation method thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN101468103A (en) | Liver-protecting product and method for preparing the same | |
| CN103690811A (en) | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof | |
| CN114404517A (en) | Composition for gout and reducing uric acid and application and preparation method thereof | |
| CN104474472A (en) | Broadleaf holly leaf buccal tablet capable of reducing high blood pressure, high blood lipid and high blood glucose and production method of buccal tablet | |
| CN102266511B (en) | Chewable tablet for removing summer heat and strengthening stomach for children, and preparation method thereof | |
| CN113730479A (en) | Composition with health care function and preparation method and application thereof | |
| CN103404640A (en) | Liver and stomach nourishing tea and preparation method thereof | |
| CN104208339A (en) | Traditional Chinese medicine composition for treating livestock and poultry bacterial or viral diseases and preparation method thereof | |
| CN106109521A (en) | A kind of Radix Notoginseng oral liquid | |
| CN105012769A (en) | Traditional Chinese medicine composition for treating diabetes and preparation method of traditional Chinese medicine composition | |
| CN104906430A (en) | Traditional Chinese medicine preparation for treating xerophthalmia and preparation method thereof | |
| CN107753602A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof | |
| CN106072560A (en) | A kind of for health product treating gout and preparation method thereof | |
| CN105995711A (en) | Fructus phyllanthi compound preparation and preparation method thereof | |
| CN114099626A (en) | Multifunctional composition for human body health care and preparation method and application thereof | |
| CN105362674A (en) | Traditional Chinese medicine used for treating diabetes and preparation method thereof | |
| CN104306817A (en) | Pharmaceutical composition for treating ephemeral fever of dairy cow and preparation method thereof | |
| CN108967618A (en) | Inonotus obliquus health protection tea and preparation method thereof and application | |
| CN106728866A (en) | A kind of health protection tea for treating physically weak cough and preparation method thereof | |
| CN103735896A (en) | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140402 |
|
| WD01 | Invention patent application deemed withdrawn after publication |